Transduction of NKTCL cell lines with PTPRK caused a decrease in pSTAT3, which suggests that targeting this phosphatase may have therapeutic benefit for these patients [68]. This evidence concerns the gene PTPRK and extranodal nasal NK/T cell lymphoma.